What this study is
Clinical trials, specifically focused on TBI, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.
The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
Study details
- Official title
- Analyzing Enrolment and Engagement Trends in Individuals Confronting TBI: Insights From TBI Clinical Trials
- Sponsor
- Power Life Sciences Inc.
- Conditions
- TBI
- Enrolling
- 500 people
- Starts
- 2025-03
- Est. completion
- 2027-03
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Ability to understand and the willingness to sign a written informed consent document
- Participant must be 18 years of age or older
- Confirmed diagnosis of TBI
You can't join if
- Enrolled in another research study
- Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
- Inability to provide written informed consent
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openPower Life Sciences
San Francisco, California, United States
- Michael B Gill · Contact415-900-4227https://www.withpower.com/contact-us@withpower.com
Study team
Sponsor
Power Life Sciences Inc.
Study ID 53955721
Study director
Michael B Gill
Power Life Sciences Inc.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.